SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $60.00 price target on the stock.
SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $77.00 price target on the stock.
Analyst Estimates: Here's What Brokers Think Of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Report [Yahoo! Finance]
SpringWorks' Q3 Loss Narrower Than Expected, Revenues Miss Mark [Yahoo! Finance]
SpringWorks Therapeutics Inc (SWTX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]